Dermatology 2013

Notes: Ramirez-Fort, Marigdalia K

Lastra-Vicente, Rosana

Levitt, Jacob O

Sanchez, Jorge L

Reizner, George T

eng

England

2012/11/02 06:00

Int J Dermatol. 2013 Mar;52(3):342-9. doi: 10.1111/j.1365-4632.2012.05750.x. Epub 2012 Nov 1.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23113920

Author Address: Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

 

 

Reference Type:  Journal Article

Record Number: 4314Author: Rathod, S. S., Motghare, V. M., Deshmukh, V. S., Deshpande, R. P., Bhamare, C. G. and Patil, J. R.

Year: 2013

Title: Prescribing practices of topical corticosteroids in the outpatient dermatology department of a rural tertiary care teaching hospital

Journal: Indian J Dermatol

Volume: 58

Issue: 5

Pages: 342-5

Date: Sep

Short Title: Prescribing practices of topical corticosteroids in the outpatient dermatology department of a rural tertiary care teaching hospital

Alternate Journal: Indian journal of dermatology

ISSN: 1998-3611 (Electronic)

0019-5154 (Linking)

DOI: 10.4103/0019-5154.117293

PMCID: 3778770

Accession Number: 24082175

Abstract: BACKGROUND: Inappropriate or excessive use of topical corticosteroids can lead to cutaneous and systemic adverse effects which occur more commonly with the use of very potent steroids. Monitoring and analysis of the prescription practices of topical steroids can help to achieve rational prescription of these drugs. AIM: The present study was carried out to study and analyze the pattern of prescribing topical corticosteroids among outpatients attending the dermatology clinic in a rural tertiary care and teaching hospital, Ambajogai, Maharashtra. MATERIALS AND METHODS: A cross-sectional descriptive study was conducted for a duration of two months from August 2011 to September 2011, and 500 prescriptions were randomly collected from the dermatology pharmacy and analyzed. RESULTS: About 66% of the prescriptions contained four to five drugs per prescription. Topical steroids were given in 28.4% of all the prescriptions. In almost all the prescriptions, strength, quantity of the steroid to be used, frequency, site, and duration of application was not mentioned. The chief complaints and diagnoses were not mentioned in about 85% of the prescriptions for topical corticosteroids. About 94.36% of the prescriptions contained very potent steroids. CONCLUSION: Inadequate prescribing information is a clear characteristic of the dermatological prescriptions containing topical corticosteroids. Doctors should be educated about the importance of giving patients sufficient information regarding the use of steroids. There is a need to revise hospital formulary where low-potency steroids can also be included along with potent ones so that the latter can be avoided in conditions where they are unnecessary.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295